SCHEMBL30919035

SCHEMBL30919035

CCOCC(C)(C)COc1ccc2nc(C(=O)NC3(C)CCS(=O)(=O)CC3)c(C)n2c1

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 17/20 0.61
BACE1 P56817 1/20 0.36
GABRA1 P14867 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30919128 0.82 DGAT2 (0.64) DGAT2BACE1
SCHEMBL30919169 0.81 DGAT2 (0.65) DGAT2BACE1GABRA1
SCHEMBL30919040 0.80 DGAT2 (0.66) DGAT2BACE1KMT2A
SCHEMBL30919235 0.80 DGAT2 (0.59) DGAT2BACE1
SCHEMBL30919156 0.78 DGAT2 (0.66) DGAT2
SCHEMBL30919054 0.78 DGAT2 (0.74) DGAT2
SCHEMBL30919192 0.78 DGAT2 (0.78) DGAT2
SCHEMBL30919075 0.77 DGAT2 (0.77) DGAT2
SCHEMBL30919113 0.77 DGAT2 (0.77) DGAT2
SCHEMBL30919096 0.76 DGAT2 (0.56) DGAT2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612151-A1 PREPARATION OF IMIDAZOPYRIDINE AND IMIDAZOPYRIDAZINE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS Merck Sharp & Dohme LLC (US) 2025-09-10 EP claimed
WO-2024097573-A1 PREPARATION OF IMIDAZOPYRIDINE AND IMIDAZOPYRIDAZINE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS MERCK SHARP & DOHME LLC (US) 2024-05-10 WO claimed
EP-4612151-A1 PREPARATION OF IMIDAZOPYRIDINE AND IMIDAZOPYRIDAZINE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS Merck Sharp & Dohme LLC (US) 2025-09-10 EP disclosed
WO-2024097573-A1 PREPARATION OF IMIDAZOPYRIDINE AND IMIDAZOPYRIDAZINE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS MERCK SHARP & DOHME LLC (US) 2024-05-10 WO disclosed